Akili Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS

Ticker Exchange SIC # Website Latest Ticker
AKLI Nasdaq 3845 https://www.akiliinteractive.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Akili Inc

Akili, Inc. (NASDAQ:AKLI) Q4 2022 Earnings Call Transcript - Mar 13th, 2023 3:51 pm
Q4 2022 Akili Inc Earnings Call - Mar 8th, 2023 1:32 pm
Akili Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update - Mar 7th, 2023 9:01 pm
Akili, Inc.'s (NASDAQ:AKLI) market cap up US$26m last week, benefiting both individual investors who own 26% as well as insiders - Feb 8th, 2023 4:37 pm
Akili to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, March 7 at 4:30 p.m. ET - Feb 6th, 2023 12:00 pm
Akili to Participate in the Cowen 43rd Annual Health Care Conference - Feb 2nd, 2023 12:00 pm
Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference - Jan 6th, 2023 3:43 pm
Pivotal Trial of EndeavorRxⓇ in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes - Jan 5th, 2023 12:00 pm
Morgan Stanley Initiates Coverage On This Digital Therapeutics Stock With Attractive View - Dec 29th, 2022 7:44 pm
Chamath Palihapitiya Stocks: 10 Stocks Picked in the Last 10 Years - Dec 27th, 2022 4:05 pm
Akili Announces ADHD Expert Dr. Scott Kollins to Join as Chief Medical Officer - Dec 1st, 2022 12:00 pm
Akili Third Quarter 2022 Earnings: EPS: US$1.38 (vs US$16.67 loss in 3Q 2021) - Nov 19th, 2022 12:52 pm
Akili Reports Third Quarter 2022 Financial Results and Company Update - Nov 10th, 2022 9:01 pm
Down More Than 50%: These 3 “Strong Buy” Stocks Are Too Cheap to Ignore - Nov 1st, 2022 3:53 pm
Financial Industry Veteran Mary Hentges Joins Akili’s Board of Directors - Oct 27th, 2022 11:00 am
Akili to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 10 at 4:30 p.m. ET - Oct 19th, 2022 11:00 am
Akili Launches EndeavorRx® Expedition - A Direct-to-Patient Product Registry - Sep 21st, 2022 11:00 am
Akili to Participate in LifeSci Partners HealthTech Symposium - Sep 19th, 2022 11:00 am
Akili 'took the last decade to clinically validate' its video game treatment for ADHD: CEO - Aug 22nd, 2022 8:08 pm